Search

everythinglearnresearchcommunity

for

Search:↓

Doctors are prescribing spironolactone more often to treat acne and skin conditions in teenagers, and it seems safe and well-tolerated.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Baricitinib is effective and safe for treating severe alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Statins do not help improve alopecia areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Stabilizing HIF-1A in hair follicles may reduce oxidative stress and promote hair growth by increasing glycolysis.

Er:YAG laser therapy effectively treats Hailey-Hailey disease, leading to long-term remission and improved quality of life.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Baricitinib successfully treated severe hair loss.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The use of Diane-35 and its generics significantly decreased in the Netherlands.